During the last session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)’s traded shares were 0.35 million, with the beta value of the company hitting 2.35. At the
During the last session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)’s traded shares were 0.36 million, with the beta value of the company hitting 2.33. At the
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)’s traded shares stood at 0.31 million during the last session, with the company’s beta value hitting 2.38. At the close
In last trading session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) saw 0.58 million shares changing hands with its beta currently measuring 2.40. Company’s recent per share
During the last session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)’s traded shares were 0.31 million, with the beta value of the company hitting 3.38. At the
Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)’s traded shares stood at 0.56 million during the last session, with the company’s beta value hitting 3.36. At the close
In last trading session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) saw 0.33 million shares changing hands with its beta currently measuring 3.28. Company’s recent per share
During the last session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)’s traded shares were 0.75 million, with the beta value of the company hitting 3.30. At the
In last trading session, Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT) saw 0.67 million shares changing hands with its beta currently measuring 2.68. Company’s recent per share
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
